Physician profile
Kendra E Mccarty
NPI 1518281815
$10,955.84
in general payments reported to CMS, 2019-2025
32 companies · $2,136 in 2025
The $2,136 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,875 · 2022: $1,967 · 2023: $2,901 · 2024: $2,077 · 2025: $2,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,647 · Education: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,647.17 |
| Education | $467.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,799.01 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,172.45 | 2021-2025 | |
| Janssen Biotech, INC. | $1,014.29 | 2021-2025 | Tremfya |
| Genzyme Corporation | $911.40 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $844.24 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Leo Pharma INC. | $811.27 | 2021-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $632.58 | 2021-2025 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $482.06 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $411.38 | 2022-2024 | Sotyktu |
| Amgen INC. | $369.81 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $366.46 | 2021-2025 | Taltz, Ebglyss |
| Galderma Laboratories, L.P. | $317.39 | 2021-2025 | Nemluvio, Aklief, Epsolay |
| Pfizer INC. | $226.94 | 2021-2024 | |
| Epi Health, LLC | $203.79 | 2021-2022 | |
| Almirall LLC | $177.55 | 2021-2023 | Seysara |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $170.52 | 2023-2024 | Ycanth |
| Incyte Corporation | $169.16 | 2021-2025 | Opzelura |
| Allergan, INC. | $124.94 | 2021-2022 | |
| Organon LLC | $117.71 | 2025 | Vtama |
| Ucb, INC. | $105.16 | 2022-2025 | Bimzelx |
| Vyne Pharmaceuticals INC. | $101.37 | 2021 | |
| Botanix Sb INC | $89.58 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $81.04 | 2021-2023 | Jublia, Arazlo, Duobrii |
| Dermavant Sciences, INC. | $53.01 | 2023-2024 | Vtama |
| Elekta, INC. | $40.22 | 2024 | Elekta Medical Linear Accelerator |
| Lnhc, INC | $34.05 | 2025 | Zelsuvmi |
| Journey Medical Corporation | $30.17 | 2022-2024 | |
| Springworks Therapeutics, INC. | $21.79 | 2025 | Gomekli |
| Dermira, INC. | $20.93 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $19.68 | 2022 | |
| Merz North America, INC. | $18.40 | 2023 | |
| Mayne Pharma Commercial LLC | $17.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.